Literature DB >> 11208073

Hermansky-Pudlak syndrome and related disorders of organelle formation.

M Huizing1, Y Anikster, W A Gahl.   

Abstract

Hermansky-Pudlak syndrome (HPS) consists of a group of genetically heterogeneous disorders which share the clinical findings of oculocutaneous albinism, a platelet storage pool deficiency, and some degree of ceroid lipofuscinosis. Related diseases share some of these findings and may exhibit other symptoms and signs but the underlying defect in the entire group of disorders involves defective intracellular vesicle formation, transport or fusion. Two HPS-causing genes, HPS1 and ADTB3A, have been isolated but the function of only the latter has been determined. ADTB3A codes for the beta 3A subunit of adaptor complex-3, responsible for vesicle formation from the trans-Golgi network (TGN). The many HPS patients who do not have HPS1 or ADTB3A mutations have their disease because of mutations in other genes. Candidates for these HPS-causing genes include those responsible for mouse models of HPS or for the 'granule' group of eye color genes in Drosophila. Each gene responsible for a subset of HPS or a related disorder codes for a protein which almost certainly plays a pivotal role in vesicular trafficking, inextricably linking clinical and cell biological interests in this group of diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208073     DOI: 10.1034/j.1600-0854.2000.011103.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  38 in total

Review 1.  Normal and abnormal secretion by haemopoietic cells.

Authors:  J C Stinchcombe; G M Griffiths
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

Review 2.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

3.  Involvement of vps33a in the fusion of uroplakin-degrading multivesicular bodies with lysosomes.

Authors:  Xuemei Guo; Liyu Tu; Iwona Gumper; Heide Plesken; Edward K Novak; Sreenivasulu Chintala; Richard T Swank; Gregory Pastores; Paola Torres; Tetsuro Izumi; Tung-Tien Sun; David D Sabatini; Gert Kreibich
Journal:  Traffic       Date:  2009-05-26       Impact factor: 6.215

4.  Hermansky-pudlak syndrome: report of a case and review of the literature.

Authors:  Matthew T Hurford; Christopher Sebastiano
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans.

Authors:  Leonie C Jacobs; Andreas Wollstein; Oscar Lao; Albert Hofman; Caroline C Klaver; André G Uitterlinden; Tamar Nijsten; Manfred Kayser; Fan Liu
Journal:  Hum Genet       Date:  2012-10-11       Impact factor: 4.132

6.  Black kidney in Albinism.

Authors:  Mohammad-Reza Ardalan
Journal:  J Nephropathol       Date:  2014-04-01

7.  Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome.

Authors:  Duarte C Barral; José S Ramalho; Ross Anders; Alistair N Hume; Holly J Knapton; Tanya Tolmachova; Lucy M Collinson; David Goulding; Kalwant S Authi; Miguel C Seabra
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 8.  The platelet release reaction: just when you thought platelet secretion was simple.

Authors:  Qiansheng Ren; Shaojing Ye; Sidney W Whiteheart
Journal:  Curr Opin Hematol       Date:  2008-09       Impact factor: 3.284

Review 9.  Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity.

Authors:  Michael S Marks; Alexander C Theos; Graça Raposo
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner.

Authors:  Satoko Oyama; Hidekuni Yamakawa; Noboru Sasagawa; Yoshio Hosoi; Eugene Futai; Shoichi Ishiura
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.